Neuromuscular

Episodes 1-16 of 25

• 

  RestartResume

  Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions 

  RestartResume

  Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions 

  MinuteCE®

  Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy 

  RestartResume

  FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy 

  MinuteCE®

  FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies 

  RestartResume

  Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies 

  MinuteCE®

  Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  MinuteCE®

  Improving Outcomes Earlier in Generalized Myasthenia Gravis:  Roadmap for Incorporating Targeted Therapies Into Clinical Practice  

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 credit 10 episodes

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 credit 10 episodes

• 

  RestartResume

  Beyond the Symptoms: The True Impact of gMG on Patients' Lives 

  RestartResume

  Beyond the Symptoms: The True Impact of gMG on Patients' Lives 

  MinuteCE®

  Beyond the Symptoms: The True Impact of gMG on Patients' Lives 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Understanding Disease Progression: The Shift From Ocular to Generalized MG 

  RestartResume

  Understanding Disease Progression: The Shift From Ocular to Generalized MG 

  MinuteCE®

  Understanding Disease Progression: The Shift From Ocular to Generalized MG 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Life-Threatening Events: Understanding and Preventing Myasthenic Crisis 

  RestartResume

  Life-Threatening Events: Understanding and Preventing Myasthenic Crisis 

  MinuteCE®

  Life-Threatening Events: Understanding and Preventing Myasthenic Crisis 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Diagnosing gMG: Navigating Current Tools and Approaches 

  RestartResume

  Diagnosing gMG: Navigating Current Tools and Approaches 

  MinuteCE®

  Diagnosing gMG: Navigating Current Tools and Approaches 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Autoantibodies in MG: Their Role in Diagnosis and Treatment 

  RestartResume

  Autoantibodies in MG: Their Role in Diagnosis and Treatment 

  MinuteCE®

  Autoantibodies in MG: Their Role in Diagnosis and Treatment 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid 

  RestartResume

  Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid 

  MinuteCE®

  Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

  RestartResume

  The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

  MinuteCE®

  The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

• 

  MinuteCE®

  Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 credit 10 episodes

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 credit 10 episodes

• 

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  MinuteCE®

  Decoding CIDP: Exploring Common and Atypical Variants

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  MinuteCE®

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  MinuteCE®

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit